REFERENCE
1. Nicholson T, Duncan DF, White JB. Is recreational drug use normal? J
Subst Use. 2002 Jan 1;7(3):116–23.
2. SHANNON M. Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pediatr
Emerg Care. 2000;16(5).
3. Walubo A, Seger D. Fatal multi-organ failure after suicidal overdose
with MDMA, “Ecstasy”: Case report and review of the literature. Hum
Exp Toxicol. 1999;18(2):119–25.
4. Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr.
2004;16(2):206–10.
5. Eede H Vanden, Montenij LJ, Touw DJ, Norris EM. Rhabdomyolysis in
MDMA intoxication: A rapid and underestimated killer. “clean” Ecstasy,
a safe party drug? Journal of Emergency Medicine. 2012;42(6):655–8.
6. Cunningham M. Ecstasy-induced rhabdomyolysis and its role in the
development of acute renal failure. Intensive Crit Care Nurs.
1997;13(4):216–23.
7. Halachanova V. Delayed rhabdomyolysis after ecstasy use [3]. Mayo
Clin Proc. 2001;76(1):112–3.
8. Bedry R, Baudrimont I, Deffieux G, Creppy EE, Pomies JP, Ragnaud JM,
et al. Wild-Mushroom Intoxication as a Cause of Rhabdomyolysis. New
England Journal of Medicine. 2001 Sep 13;345(11):798–802.
9. Benjamin A, Anderson A, Zrelec S. Delayed rhabdomyolysis secondary to
anabolic-androgenic steroid use. Clin Med (Lond). 2020
Nov;20(6):e260–1.
10. Russell T, Riazi S, Kraeva N, Steel AC, Hawryluck LA.
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant
syndrome in a patient with a novel variant in the ryanodine receptor
type 1 gene. Anaesthesia. 2012;67(9):1021–4.
11. Lehmann ED, Thom CH, Croft DN. Delayed severe rhabdomyolysis after
taking “ecstasy”. Vol. 71, Postgraduate medical journal. England;
1995. p. 186–7.
12. Luckoor P, Salehi M, Kunadu A. Exceptionally high creatine kinase
(CK) levels in multicausal and complicated rhabdomyolysis: A case
report. American Journal of Case Reports. 2017;18:746–9.
13. Ramcharan S, Meenhorst PL, Otten JMMB, Koks CHW, De Boer D, Maes
RAA, et al. Survival after massive ecstasy overdose. J Toxicol Clin
Toxicol. 1998;36(7):727–31.
14. Hall AP, Henry JA. Acute toxic effects of ‘ Ecstasy ’ ( MDMA ) and
related compounds : overview of pathophysiology and clinical
management. Br J Anaesth. 2006;96(6):678–85.
15. Bora F, Yılmaz F, Bora T. Ecstasy ( MDMA ) and its effects on
kidneys and their treatment : a review Ecstasy ( Unit ).
16. Ricaurte GA, Mccann UD. doi:10.1016/S0140-6736(05)66737-2.
2005;1–9.
17. Frank A. Mangano, Mark Zaontz JJP. Computed tomography of Acute
Renal Failure Secondary to Rhbdomyolysis. 1985. p. 777–9.
18. Nakahara K, Tanaka H, Masutani K, Yanagida T, Kashiwagi M, Mizumasa
T, et al. The value of computed tomography and magnetic resonance
imaging to diagnose rhabdomyolysis in acute renal failure. Nephrology
Dialysis Transplantation. 1999;14(6):1564–7.
19. Moratalla MB, Braun P, Fornas GM. Importance of MRI in the diagnosis
and treatment of rhabdomyolysis. Eur J Radiol. 2008;65(2):311–5.
20. Candela N, Silva S, Georges B, Cartery C, Robert T, Moussi-Frances
J, et al. Short- and long-term renal outcomes following severe
rhabdomyolysis: a French multicenter retrospective study of 387
patients. Ann Intensive Care. 2020;10(1):1–7.
21. Akkina SK, Ricardo AC, Patel A, Das A, Bazzano LA, Brecklin C, et
al. Illicit drug use, hypertension, and chronic kidney disease in the US
adult population. Transl Res. 2012 Dec;160(6):391–8.
22. Vupputuri S, Batuman V, Muntner P, Bazzano LA, Lefante JJ, Whelton
PK, et al. The risk for mild kidney function decline associated with
illicit drug use among hypertensive men. Am J Kidney Dis. 2004
Apr;43(4):629–35.